unknown
Stage
2021
Founded
1
Investors
About
Aerion Bioscience develops a blood-based cancer screening technology for early detection of lung cancer through non-invasive diagnostic testing, using plasma-based biomarker analysis and proprietary protein panels.
Explore Aerion Bioscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.